Home › Polygraph Research › Beyond the Polygraph: Deception Detection and the Autonomic…
Catalogue entry · Neuroimaging & New Technologies
Beyond the Polygraph: Deception Detection and the Autonomic Nervous System
Lonnie G. Cook; Charles Mitschow — Federal Practitioner, 36(7), 316–321,
Review of deception detection methods beyond traditional polygraph, including fMRI, EEG, thermal imaging, and cognitive-based approaches. Assessed readiness of each technology for practical deployment.
Abstract
Review of deception detection methods beyond traditional polygraph, assessing readiness of fMRI, EEG, thermal imaging, and cognitive approaches for deployment.
Methodology
Neuroimaging study using fMRI, EEG/ERP, or other brain measurement technology to examine neural correlates of deception or concealed information.
Detailed summary
Published in 2019 in Federal Practitioner, 36(7), 316–321, this work by Cook and colleagues examined beyond the polygraph: deception detection and the autonomic nervous system. Key findings include: Review of deception detection methods beyond traditional polygraph, including fMRI, EEG, thermal imaging, and cognitive-based approaches. Assessed readiness of each technology for practical deployment. This research contributes to the evolving understanding of how advanced technologies can enhance or complement traditional polygraph methods.
Implications for polygraph practice
Despite decades of research, traditional autonomic polygraph remains the most validated and deployable deception detection technology.
Comprehensive study analysis
An in-depth, original analysis of this research study's methodology, findings, and significance for the polygraph profession.
Background & Context
The traditional polygraph has served as the cornerstone of deception detection in U.S. Department of Defense security screenings and law enforcement investigations for decades. However, this 2019 review by Cook and Mitschow emerged from a critical clinical observation: polygraph results are vulnerable to inaccuracies in subjects with autonomic disorders and may be confounded by multiple medications. This represents a significant and underappreciated vulnerability in an era where both medical conditions affecting the autonomic nervous system and polypharmacy are increasingly prevalent.
The authors, writing from Naval Medical Center Portsmouth, brought a unique neurological and psychiatric perspective to polygraph science. Their work addresses a fundamental limitation of autonomic-based testing: by using vital signs as an indirect measurement of deception-induced stress, the polygraph machine may provide a false positive or negative result if a patient has an inherited or acquired condition that affects the autonomic nervous system. This gap is particularly relevant in military medicine, where personnel subject to polygraph testing may have conditions ranging from alcohol use disorder to rheumatoid arthritis—all capable of disrupting autonomic function.
The paper also evaluated emerging neuroimaging technologies as potential alternatives that bypass these autonomic vulnerabilities. When asked to discern truth from falsehood based on their own perceptions, people correctly discern lies as false merely 47% of the time and truth as nondeceptive about 61% of the time, underscoring why technological assistance remains critical despite polygraph limitations.
Research Design & Methodology
This was a comprehensive narrative review examining deception detection technologies, with particular emphasis on how autonomic nervous system dysfunction affects polygraph validity and how emerging technologies might circumvent these limitations. The authors systematically reviewed physiological mechanisms, medical conditions, pharmacological effects, and alternative detection modalities including functional magnetic resonance imaging (fMRI), electroencephalography (EEG), and thermal imaging.
The review specifically examined:
- Autonomic disorders: Conditions affecting the autonomic nervous system, including small fiber autonomic neuropathies, synucleinopathies (Parkinson's disease), diabetes mellitus, rheumatoid arthritis, and alcoholism
- Medication effects: Commonly prescribed drugs affecting autonomic function, including beta blockers, sympathomimetics, anticholinergics, and antimalarial medications like mefloquine
- Emerging technologies: fMRI detecting dorsolateral prefrontal cortex activation during deception, EEG/event-related potentials measuring cortical activity, and other modalities not dependent on autonomic measurements
- Practical deployment readiness: Cost, equipment requirements, personnel training needs, and field applicability of each technology
The authors drew on neurological literature, polygraph research, pharmacology studies, and neuroimaging investigations to assess each technology's current state and readiness for operational use. Their clinical perspective as a neurologist and psychiatrist provided unique insight into the medical factors that could compromise traditional polygraph accuracy.
Results & Key Findings
The review's central conclusion was that dysautonomias represent an underappreciated source of polygraph error. Dysautonomias may be an underappreciated cause of error in polygraph interpretation, and polygraph examiners and DoD agencies should be aware of the potential for these disorders to interfere with interpretation of results.
Key findings on medical confounds included:
- Disease prevalence: Approximately 60% of patients with rheumatoid arthritis have blunted cardiovagal baroreceptor responses and heart rate variability, and patients with diabetes mellitus often have elevated resting heart rate and low heart rate variability due to dysregulated β-adrenergic activity
- Medication effects: Beta blockers reduce heart rate, heart rate variability, cardiac contractility, and blood pressure, causing patients taking β blockers to have a blunted physiologic response to stress and increased likelihood of inconclusive or false-negative polygraph exams
- Common medication prevalence: Of the 10 most prescribed medications of 2016, 5 have direct effects on the ANS
- Research gap: No study has been performed on the validity of polygraphy in patients with any form of dysautonomia
Regarding emerging technologies, the review found:
- fMRI capabilities: When someone is engaged in active deception, the dorsolateral prefrontal cortex has greater perfusion than when engaged in truth telling, and fMRI may have superior sensitivity and specificity for lie detection compared with conventional polygraphy
- fMRI limitations: Significant limitations include the necessity of expensive specialized equipment and trained personnel to operate the MRI, plus exclusion of subjects with metallic implants
- EEG advantages: Benefits of EEG compared with fMRI include large reductions in cost, space, and restrictions for use; however, like fMRI, EEG still requires trained personnel to operate and interpret, and has yet to be tested outside of the laboratory
Discussion & Significance
This review filled a critical gap by explicitly connecting clinical neurology with polygraph practice. The authors highlighted that the polygraph field has operated for decades without systematic consideration of how common medical conditions and medications might compromise test validity. This represents a significant practical concern given that a variety of diseases from alcohol use disorder to rheumatoid arthritis can affect the ANS, a multitude of commonly prescribed drugs can affect the ANS, and over-the-counter medications like pseudoephedrine and diphenhydramine can increase heart rate and blood pressure.
The paper's assessment of emerging technologies offered a balanced perspective. While fMRI and EEG deception detection techniques circumvent autonomic issues and may be utilized in the near future to avoid these pitfalls, the authors acknowledged substantial practical barriers. The costs, technical requirements, and lack of field validation mean these technologies remain years from operational deployment. This sober assessment contrasts with more optimistic projections elsewhere in the literature.
Perhaps most importantly, the authors challenged the polygraph community to recognize that while emerging technologies may allow superior accuracy by bypassing ANS-based physiologic outputs, the polygraph examiner and physician must be aware of the effect of autonomic dysfunction and medications that affect the ANS, particularly within military medicine where many patients are subject to polygraph examination. This represents a call for medical screening protocols and examiner education rather than wholesale replacement of existing technology.
Limitations & Considerations
As a narrative review rather than systematic analysis, this paper did not employ formal meta-analytic techniques or comprehensive literature search protocols. The authors acknowledged their focus on medical confounds without providing quantitative estimates of how frequently these issues actually affect polygraph outcomes in practice. No study has been performed on the validity of polygraphy in patients with any form of dysautonomia, meaning the magnitude of this problem remains empirically unknown.
The review also noted significant limitations in the alternative technologies discussed. Bioethical and legal concerns have been raised that measuring brain activity during interrogation may endanger "cognitive freedom" and may even be considered unreasonable search and seizure under the Fourth Amendment. Additionally, the idea of fMRI as "mind reading" is largely a misconception, as these technologies measure physiological correlates rather than thoughts directly.
The paper's exclusive focus on autonomic confounds meant other polygraph limitations—such as countermeasures, examiner variability, and psychological factors—received minimal attention. The authors also did not address how their recommendations might be implemented in existing polygraph programs or what screening procedures might identify at-risk examinees.
Practical Applications
This review has immediate implications for polygraph practice. Examiners should implement medical screening protocols to identify examinees with autonomic disorders or taking medications that affect autonomic function. Beta blockers, widely prescribed for hypertension and anxiety, deserve particular attention given their profound effects on cardiovascular responses. Even common over-the-counter medications like antihistamines and decongestants can alter physiological patterns measured by the polygraph.
For consumers and examinees, this paper provides critical context. Individuals with diabetes, Parkinson's disease, rheumatoid arthritis, or history of alcoholism may have autonomic dysfunction that could compromise test validity. Those taking prescribed or over-the-counter medications affecting heart rate, blood pressure, or sweating should disclose these to examiners. The paper suggests that test results for such individuals warrant more cautious interpretation, potentially leading to "inconclusive" rather than "deceptive" determinations when physiological responses are blunted or atypical. Military personnel and federal employees subject to screening should be aware that legitimate medical conditions, not deception, might affect their results.
The analysis above is original editorial content based on our review of this research. For the complete study including full data, methodology details, and author discussion, access the original publication below.
References in our database [3]
Studies cited by this paper that are available in our research database.
Related research
Other studies in this category that may be of interest.
Modes of visual framing in neuropsychological deception detection research
[002] (2026)Enhanced visualisation of concealed target objects by infrared thermography and machine learning
[003] (2026)Buyer–Seller-Deception-Game Dataset: A new comprehensive dataset for facial expression based deception detection…
[004] (2026)A novel method based on variational mode decomposition for lie detection
[005] (2026)Influence of Stimulus Layout and Social Presence on Deception-Related Eye Movements and…
[006] (2026)Neural Signatures of Deception: An Explainable Machine LearningApproach Using EEG Signals
Join Our Examiner Network
APA-trained examiners using validated techniques can apply to join the LieDetectorTest.com network.
Keep reading the ledger.
Every peer-reviewed study on polygraph and deception detection we track — catalogued, searchable and citable.

